[APDN] Applied DNA Sciences Inc


Type of security: Stock

Sector: Consumer Services

Industry: Other Consumer Services

Market Capitalization: 77.3 M

Exchange: NASDAQ

The data is delayed by 15 minutes.


Price: 2 Change: -0.05 (-2.44%)
Ext. hours: Change: 0 (0%)

chart APDN

Refresh chart

Strongest Trends Summary For APDN

APDN is in the long-term down -95% below S&P in 10 years.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart


Description: Applied DNA Sciences, Inc. provides botanical-DNA based anti-counterfeiting and product authentication solutions for supply chain security, brand protection, and law enforcement applications in the United States, Europe, and Asia. The company offers SigNature DNA markers for embedment into a range of media, such as inks, dyes, textile treatments, thermal ribbon thread, laminates, glues, threads, varnishes, adhesives, and metal coatings; SigNature T botanical DNA markers for use in brand protection efforts and raw material source compliance programs; and SmartDNA, a patented security system for stores, warehouses, banks, pharmacies, and ATMs, as well as for the protection of valuables. It also provides DNANet tactical DNA products for law enforcement in the form of DNA-marked fixative sprays and liquids; digitalDNA, a DNA-secured form of the quick read code to create customer interface; fiberTyping solution, which is used in DNA verification for manufacturers, retailers, and brand owners to ensure quality, saf

Fundamental Ratios
Shares Outstanding24.08 M EPS-0.53 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 80.62% Sales Growth - Q/Q22.3% P/E-1.89
P/E To EPS Growth P/S18.2 P/BV39.54 Price/Cash Per Share
Price/Free Cash Flow-8.84 ROA-378.83% ROE-702.45% ROI
Current Ratio1.38 Quick Ratio Long Term Debt/Equity Debt Ratio0.85
Gross Margin Operating Margin-259.56% Net Profit Margin-323.45% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities3.8 M Cash From Investing Activities-230 K Cash From Operating Activities-3.97 M Gross Profit
Net Profit-1.89 M Operating Profit-1.88 M Total Assets3.63 M Total Current Assets2.3 M
Total Current Liabilities1.67 M Total Debt Total Liabilities1.67 M Total Revenue1.52 M
Technical Data
High 52 week2.68 Low 52 week1.11 Last close1.12 Last change-4.27%
RSI16.67 Average true range0.09 Beta0.35 Volume207.81 K
Simple moving average 20 days-17.19% Simple moving average 50 days-13.63% Simple moving average 200 days-20.54%
Performance Data
Performance Week-9.68% Performance Month-24.83% Performance Quart-18.84% Performance Half-25.33%
Performance Year-54.47% Performance Year-to-date-29.56% Volatility daily3.32% Volatility weekly7.43%
Volatility monthly15.24% Volatility yearly52.78% Relative Volume261.52% Average Volume146.41 K
New High New Low


2020-05-21 11:11:00 | Applied DNA to Participate in Maxim Group’s COVID-19 Virtual Conference Series on May 27

2020-05-19 06:23:07 | News Flash: One Applied DNA Sciences, Inc. NASDAQ:APDN Analyst Has Been Trimming Their Revenue Forecasts

2020-05-16 08:15:43 | Analysts Have Lowered Expectations For Applied DNA Sciences, Inc. NASDAQ:APDN After Its Latest Results

2020-05-15 10:43:40 | Applied DNA Sciences Tackles COVID-19 on Three Fronts; Analyst Says ‘Buy’

2020-05-15 06:13:53 | Those Who Purchased Applied DNA Sciences NASDAQ:APDN Shares Five Years Ago Have A 85% Loss To Show For It

2020-05-15 03:29:00 | Edited Transcript of APDN earnings conference call or presentation 14-May-20 8:30pm GMT

2020-05-14 16:05:00 | Applied DNA Reports 2020 Fiscal Second Quarter Financial Results

2020-05-14 09:59:00 | Applied DNA's Coronavirus Test Cleared by FDA for Emergency Use

2020-05-14 08:32:43 | The Daily Biotech Pulse: ASCO Abstracts Create Stock Ripples, Applied DNA's Coronavirus Test Receives EUA, Biopharmx Shareholders Vet Reverse Merger

2020-05-14 07:12:00 | Shares of Applied DNA Sciences jump 66% on regulatory authorization of its COVID-19 test

2020-05-14 05:00:00 | Applied DNA Receives FDA Emergency Use Authorization for COVID-19 Diagnostic Assay Kit

2020-05-07 08:00:00 | Applied DNA Schedules Fiscal 2020 Second Quarter Financial Results Conference Call for Thursday, May 14, 2020 at 4:30 PM ET

2020-05-06 08:00:00 | Applied DNA Receives Approximately $5.3 Million in Net Proceeds from Warrant Exercise

2020-05-05 09:32:00 | Applied DNA Applies to U.S. FDA for Emergency Use Authorization for COVID-19 Diagnostic Kit

2020-05-04 03:00:00 | Applied DNA and Takis Biotech Announce the Production of Neutralizing Antibodies Against SARS-CoV-2 After DNA Vaccination in Animals

2020-04-30 17:25:32 | Applied DNA Accepted Into U.S. FDA’s Emerging Technology Program, Creating Pathway for Molecular Tagging of Pharmaceuticals and Packaging

2020-04-21 08:19:58 | The Daily Biotech Pulse: Applied DNA Begins Validating COVID-19 Test, Cara's Positive Readout, Novan Explores Strategic Alternatives

2020-04-21 02:00:00 | Applied DNA High-Sensitivity and High-Throughput COVID-19 Diagnostic Kit Enters Validation Process in Partnership with Stony Brook University Hospital

2020-04-15 08:03:02 | The Daily Biotech Pulse: Applied DNA Ships Vaccine Constructs For Animal Testing, Herceptin Biosimilar Now Available In US

2020-04-15 06:03:00 | Applied DNA Ships COVID-19 LinearDNA™ Vaccine Candidates to Italian Development Partner to Begin Preclinical Animal Testing

2020-04-14 08:30:00 | Applied DNA to Speak on COVID-19 Panel at Maxim Group’s Infectious Disease Virtual Conference on May 5

2020-04-02 08:18:00 | Applied DNA and Takis Biotech Expand COVID-19 Vaccine Development Program to Include 5th Candidate

2020-03-31 06:35:59 | Is Applied DNA Sciences, Inc. NASDAQ:APDN Excessively Paying Its CEO?

2020-03-26 08:37:00 | Applied DNA Ships LinearDNA™ to Another Development Customer

2020-03-24 08:20:34 | The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test

2020-03-24 07:00:00 | Applied DNA Files Provisional Patent Application for High Sensitivity COVID-19 Diagnostic Assay with U.S. Patent and Trademark Office

2020-03-20 11:29:00 | Applied DNA Secures Global Top-20 Pharmaceutical Manufacturer as Drug Development Customer

2020-03-19 07:00:00 | Applied DNA Leverages COVID-19 Vaccine Development and Proprietary Linear DNA Manufacturing Capability to Design a High Sensitivity Diagnostic Kit for Virus Detection

2020-03-18 15:04:00 | Applied DNA COVID-19 Collaboration Partner Takis Biotech Receives Italy Ministry of Health Approval to Begin Testing of a Vaccine Candidate on Pre-clinical Models

2020-03-04 09:48:37 | 3 Biotech Stocks Join the Coronavirus Fight

2020-03-02 15:04:33 | Applied DNA, Takis Biotech Partner To Design COVID-19 Vaccines For Animal Testing

2020-03-02 07:51:32 | Benzinga Pro's Top 5 Stocks To Watch For Mon., Mar. 2, 2020: GILD, BIDU, CODX, MRKR, APDN

2020-03-02 04:00:00 | Applied DNA Sciences Updates on COVID-19 Collaboration with Takis Biotech, 4 Preclinical LinearDNA™ Vaccine Candidates Designed

2020-02-24 09:00:00 | Applied DNA Announces Receipt of International Patents on its Beacon® Secure Optical Molecular Marker Technologies

2020-02-20 09:00:00 | Applied DNA Receives Kosher Certification from Orthodox Union for Qualifying Products

2020-02-19 10:33:00 | Applied DNA Enters Dietary Supplements Market with Multi-Year Nutrition21 Contract

2020-02-11 15:00:29 | Edited Transcript of APDN earnings conference call or presentation 6-Feb-20 9:30pm GMT

2020-02-07 10:20:00 | Applied DNA Sciences Subsidiary, LineaRx, and Takis Biotech Collaborate for Development of a Linear DNA Vaccine Candidate Against Wuhan Coronavirus 2019-nCoV

2020-02-07 09:00:00 | Applied DNA Announces Issuance of U.S. Patent Protecting its CertainT® Platform in Man-Made Cellulosic Fibers and Materials

2020-02-06 17:50:21 | Applied DNA Reports 2020 Fiscal First Quarter Financial Results

2020-02-06 14:30:00 | Applied DNA Sciences, Inc. to Host Earnings Call

2020-01-31 07:22:03 | Who Has Been Buying Applied DNA Sciences, Inc. NASDAQ:APDN Shares?

2020-01-30 05:00:00 | Applied DNA Schedules Fiscal 2020 First Quarter Financial Results Conference Call for Thursday, February 6, 2020 at 4:30 PM ET

2020-01-27 09:00:00 | Applied DNA Announces Issuance of U.S. Patent Protecting its CertainT® Platform in Man-Made Cellulosic Fibers and Materials

2020-01-13 09:15:00 | Applied DNA Subsidiary, LineaRx, Inc., Signs Licensing Agreement with LifeSensors, Inc.

2020-01-10 09:00:00 | Applied DNA to Hold Investment Community Meetings During the JP Morgan 38th Annual Healthcare Conference and Present at the Biotech Showcase 2020

2019-12-23 09:30:00 | Colorcon, Inc. Launches On-Dose Authentication Platform From Applied DNA Sciences

2019-12-13 01:55:52 | Edited Transcript of APDN earnings conference call or presentation 12-Dec-19 9:30pm GMT

2019-12-12 16:05:00 | Applied DNA Reports 2019 Year End and Fiscal Fourth Quarter Financial Results

2019-12-12 07:38:44 | The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win